Not a one-size plan
Peptide therapy should not replace basic nutrition and movement care
Peptide and peptide-adjacent products can affect appetite, energy, recovery, skin, hair, sexual health, or weight goals in very different ways. A safe plan starts with the patient’s diagnosis, current medications, side effects, food intake, physical limitations, and follow-up access—not a generic “peptide diet” or influencer workout schedule.
- For semaglutide, tirzepatide, Wegovy, Zepbound, Ozempic, or Mounjaro, reduced appetite can make adequate protein, fluids, fiber, and tolerable meals harder during dose changes.
- For sermorelin or recovery-focused goals, clinicians may discuss sleep, training load, injury history, glucose context, IGF-1 or other labs when appropriate, and realistic body-composition expectations.
- For NAD+, glutathione, methylene blue, GHK-Cu, or PT-141, nutrition and movement questions should support the primary goal without promising anti-aging, detox, muscle-gain, or performance outcomes.